Adverse Event Rule Would Require e-Conversion Of 20 Percent Of Submissions
Executive Summary
FDA's proposed rule to require electronic submission of adverse event information would mandate a switch that industry already seems to be making rapidly
You may also be interested in...
FDA Adverse Event Electronic Reporting Delayed To Complete Portal Roll-Out
Because some submitters will not have enough time to register for new electronic submission system, FDA will continue accepting paper post-marketing safety reports a little longer.
AER Electronic Filing Rule Sets Exemption Bar At Disaster Level
FDA requires firms to submit post-market safety reports for drugs and biologics electronically beginning in June 2015. The agency says waivers will be allowed, but only will be temporary and rare, such as when disasters cut off electric power and Internet access.
AER Electronic Filing Rule Sets Exemption Bar At Disaster Level
FDA requires firms to submit post-market safety reports for drugs and biologics electronically beginning in June 2015. The agency says waivers will be allowed, but only will be temporary and rare, such as when disasters cut off electric power and Internet access.